Status:
TERMINATED
Prime Time for Superficial Femoral Artery (SFA) - The SFA Study
Lead Sponsor:
Arizona Heart Institute
Conditions:
Peripheral Vascular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the different endovascular treatment modalities for the femoropopliteal segment, and to determine technical success, efficacy and patency at mid-term follow-up....
Detailed Description
Peripheral vascular occlusive disease is a progressive and often debilitating form of atherosclerosis affecting the vessels of the upper and lower extremities. Patients typically present with complain...
Eligibility Criteria
Inclusion
- Stenosis \> 70% or total occlusion of the femoropopliteal segment that do not include the origin of the SFA.
- SFA and popliteal of \> 4 mm in diameter.
- TASC classification A, B, and C.
- At least one vessel run-off.
Exclusion
- Age \< 18 years old.
- Medical condition that may cause the patient not to be compliant with follow-up (Ex. terminal cancer).
- Pregnancy
- Unwilling or unable to comply with the follow-up.
- Inability or refusal of informed consent.
- Medical
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00902317
Start Date
November 1 2004
End Date
May 1 2009
Last Update
May 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona Heart Institute
Phoenix, Arizona, United States, 85006